Novavax Soars
Digest more
US health regulators have given final approval to Novavax's COVID vaccine after an unusual delay and have placed new restrictions on the jab, the pharmaceutical company announced Monday.
The vaccine will only be available to those at high risk from COVID—excluding those who may need it to protect a relative or friend.
The FDA finally approved Novavax's Covid-19 vaccine, but placed restrictions on it that its two competitors in the U.S. do not face